Literature DB >> 9111137

The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells.

F H Routier1, M J Davies, K Bergemann, E F Hounsell.   

Abstract

A humanized IgG antibody (D1.3) which retains murine complementarity determining regions specific for the antigen lysozyme has been expressed in CHO-DUKX cells. Heavy and light chain containing plasmids were co-transfected into CHO-DUKX cells and stable clones were grown in DMEM/F12 medium supplemented with 5% foetal calf serum. D1.3 antibody was purified from culture supernatants by Protein G chromatography. With the recombinant D1.3 antibody as a model, this cell culture system was shown to glycosylate the IgG Fc region in a similar manner to IgG isolated from serum. The neutral, core fucosylated biantennary oligosaccharides found are present in serum IgG and no novel carbohydrate sequences were detected. The degree of terminal agalactosylation was also similar to normal serum, in contrast to the increased levels found in rheumatoid serum. Furthermore, those oligosaccharides which lack only one terminal Gal are exclusively galactosylated on the GlcNAc(beta1,2) Man(alpha1,6) Man(beta1,4) antenna. Unambiguous identification of the exact glycosylation pattern of the antibody was carried out by a combination of specific exoglycosidase digestions, gel permeation chromatography of 2-aminobenzamide derivatives, high pH anion exchange chromatography and methylation analysis followed by gas-liquid chromatography-mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111137     DOI: 10.1023/a:1018589704981

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  35 in total

Review 1.  Monoclonal antibody-based therapies of leukemia and lymphoma.

Authors:  M L Grossbard; O W Press; F R Appelbaum; I D Bernstein; L M Nadler
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

2.  Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions.

Authors:  M R Lifely; C Hale; S Boyce; M J Keen; J Phillips
Journal:  Glycobiology       Date:  1995-12       Impact factor: 4.313

3.  Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst.

Authors:  J D Pound; J Lund; R Jefferis
Journal:  Mol Immunol       Date:  1993-02       Impact factor: 4.407

4.  Fast sequencing of oligosaccharides: the reagent-array analysis method.

Authors:  C J Edge; T W Rademacher; M R Wormald; R B Parekh; T D Butters; D R Wing; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material.

Authors:  J S Crowe; V S Hall; M A Smith; H J Cooper; J P Tite
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

6.  Structural study of the sugar moieties of monoclonal antibodies secreted by human-mouse hybridoma.

Authors:  M Tandai; T Endo; S Sasaki; Y Masuho; N Kochibe; A Kobata
Journal:  Arch Biochem Biophys       Date:  1991-12       Impact factor: 4.013

7.  A dominant mutation to ricin resistance in Chinese hamster ovary cells induces UDP-GlcNAc:glycopeptide beta-4-N-acetylglucosaminyltransferase III activity.

Authors:  C Campbell; P Stanley
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

8.  Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G.

Authors:  N Takahashi; I Ishii; H Ishihara; M Mori; S Tejima; R Jefferis; S Endo; Y Arata
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

9.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic.

Authors:  T W Rademacher; P Williams; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G.

Authors:  C C Ip; W J Miller; M Silberklang; G E Mark; R W Ellis; L Huang; J Glushka; H Van Halbeek; J Zhu; J A Alhadeff
Journal:  Arch Biochem Biophys       Date:  1994-02-01       Impact factor: 4.013

View more
  4 in total

1.  Lectin analysis of human immunoglobulin G N-glycan sialylation.

Authors:  M Dalziel; I McFarlane; J S Axford
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

2.  Protein multifunctionality: principles and mechanisms.

Authors:  Joseph Z Zaretsky; Daniel H Wreschner
Journal:  Transl Oncogenomics       Date:  2008-05-15

3.  Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

Authors:  Meital Edri-Brami; Benyamin Rosental; Dana Hayoun; Michael Welt; Hila Rosen; Itzhak Wirguin; Beatrice Nefussy; Vivian E Drory; Angel Porgador; Rachel G Lichtenstein
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

4.  Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®.

Authors:  Changsoo Lee; Min Jeong; JongAh Joanne Lee; Saebom Seo; Sung Chun Cho; Wei Zhang; Orlando Jaquez
Journal:  MAbs       Date:  2017-06-22       Impact factor: 5.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.